To discover the action of a drug “X” in isolated intestinal smooth muscle preparations a study was carried out. It was seen that, drug X binds to cholinergic receptors of intestine and relaxes the preparation. While in the absence of drug X, Acetylcholine acts on same receptors and contracts the preparation. It was also seen that, at a low conc. of drug X, the EC50 of acetylcholine remains unchanged, but the Emax was decreased. At a high conc. of drug X, high conc. of acetylcholine had no effect. Which of the following statement is true about the drug X?
To discover the action of a drug “X” in isolated intestinal smooth muscle preparations a study was carried out. It was seen that, drug X binds to cholinergic receptors of intestine and relaxes the preparation. While in the absence of drug X, Acetylcholine acts on same receptors and contracts the preparation. It was also seen that, at a low conc. of drug X, the EC50 of acetylcholine remains unchanged, but the Emax was decreased. At a high conc. of drug X, high conc. of acetylcholine had no effect. Which of the following statement is true about the drug X?
π‘ Explanation
**Core Concept:** Drugs can act as agonists, antagonists, or modulators at their target receptors. In this case, drug X is a modulator affecting the response to acetylcholine. Intestinal smooth muscles are under the influence of acetylcholine which acts via muscarinic receptors (M3) causing contraction.
**Why the Correct Answer is Right:** Drug X acts as a modulator of muscarinic receptors (M3) in the intestine. At low concentrations of drug X, the effect of acetylcholine (agonist) on M3 receptors remains unchanged, but the maximum response (Emax) to acetylcholine is reduced. This indicates that drug X is a competitive antagonist at the receptor, meaning it binds to the receptor site and prevents the agonist (acetylcholine) from binding, reducing the maximum response without affecting the potency (EC50).
**Why Each Wrong Option is Incorrect:**
A. False - Drug X is a competitive antagonist, which is different from a full antagonist or partial agonist.
B. False - The statement about the drug X being a full agonist or partial agonist is incorrect because it doesn't affect the potency (EC50) but reduces the maximum response (Emax).
C. False - Drug X doesn't increase the potency of acetylcholine as a full agonist would.
D. False - Drug X doesn't cause desensitization or downregulation of the muscarinic receptors, which are processes that would affect the EC50 and not Emax.
**Clinical Pearl:** Modulators play a crucial role in regulating the response of a receptor to its agonist. They are important in understanding drug action and can have significant therapeutic implications. For example, competitive antagonists like drug X can be used to reduce the side effects of full agonists (like acetylcholine) without affecting its potency, allowing for more specific treatment.
**Correct Answer:** D. Drug X is a competitive antagonist at the muscarinic receptors (M3) in the intestine.
β Correct Answer: C. Non-competitive antagonist
π€ Share this MCQ
Share Card Preview
π 1080x1080 square card β fills the full width in WhatsApp and Telegram